In negotiations with manufacturers, the administration aims to provide lower-dose weight-loss medications for about $149 a ...

During an earnings call Monday, Palantir CEO Alex Karp said the tech giant is the "first company to be completely anti-woke" ...

The probability of developing ocular EIMs was comparable across treatment classes among patients with HLA-B27-associated diseases.

The boss of the ‘Wez’ county lines gang has been jailed alongside a street dealer. Leon Crawford, 46, ran the line between ...

In the absence of much federal action, states have enacted dozens of laws this year to lower prescription drug costs for ...

The U.S. Food and Drug Administration recalled more than 580,000 bottles of a blood pressure medication. Is your medication ...

McCormick said in a press conference Thursday that he was concerned nitazenes “would become the next fentanyl,” the opioid ...

Dr. Mehmet Oz and Dr. Marty Makary touted that reducing steps for biosimilar approval will lower costs by increasing competition.

U.S. Sen. Ashley Moody is part of a bipartisan group of lawmakers who have introduced a proposed bill that would call for Nitazene, synthetic opioids, to be classified as a Schedule 1 drug under the ...

Pre-med student Valerie Xu ’28 joined the waitlist to volunteer at Hasbro Children’s Hospital, the pediatric division under ...

Akeso (9926.HK) announced that its first-in-class bispecific antibody, ivonescimab (PD-1/VEGF bispecific antibody), in combination with chemotherapy for first-line treatment of triple-negative breast ...